↩ back to the box
Post : Shorter drug treatment OK for many breast cancer patients
URL : http://nationalpost.com/pmn/pmn-life/shorter-drug-treatment-ok-for-many-breast-cancer-patients
Posted : May 16, 2018 at 1:03 pm
Author : The Associated Press
Tags : AP
Categories : PMN Life

New research suggests that many women with a common and aggressive form of breast cancer that is treated with Herceptin can get by with six months of the drug instead of the usual 12. That greatly reduces the risk of heart damage the drug can cause.

About 20 per cent of breast cancers are aided by a faulty HER2 gene, which Herceptin targets. Concern about heart side effects led doctors in the United Kingdom to test shorter use.

About 4,000 women with early-stage cancers were given chemotherapy plus Herceptin for six or 12 months. After four years, 90 per cent of both groups were alive without signs of the disease.

Results were released Wednesday by the American Society of Clinical Oncology ahead of presentation at its meeting next month.

Add a comment to this post: http://nationalpost.com/pmn/pmn-life/shorter-drug-treatment-ok-for-many-breast-cancer-patients#respond

WordPress.com | Thanks for flying with WordPress!

Manage Subscriptions